Germán Sierra-Paredes Selected Research

latrunculin A (LAT-A)

12/2014	Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.
12/2014	The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus.
10/2007	Effect of eslicarbazepine acetate (BIA 2-093) on latrunculin A-induced seizures and extracellular amino acid concentrations in the rat hippocampus.
4/2007	Changes in extracellular amino acid concentrations in the rat hippocampus after in vivo actin depolymerization with latrunculin A.
1/2006	Seizures induced by in vivo latrunculin a and jasplakinolide microperfusion in the rat hippocampus.
11/2005	Seizures induced by microperfusion of glutamate and glycine in the hippocampus of rats pretreated with latrunculin A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Germán Sierra-Paredes Research Topics

Disease

9	Seizures (Absence Seizure) 12/2014 - 05/2005
2	Epilepsy (Aura) 12/2014 - 08/2007
1	Brain Diseases (Brain Disorder) 12/2014
1	Skin Diseases (Skin Disease) 01/2008
1	Central Nervous System Diseases (CNS Diseases) 01/2008

Drug/Important Bio-Agent (IBA)

6	latrunculin A (LAT-A)IBA 12/2014 - 11/2005
5	Anticonvulsants (Antiepileptic Drugs)IBA 12/2014 - 01/2006
4	PicrotoxinIBA 10/2007 - 05/2005
3	eslicarbazepine acetateIBA 12/2014 - 12/2006
2	Amino Acids FDA Link 12/2014 - 10/2007
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2014 - 01/2008
2	immunomycin (ascomycin)IBA 01/2008 - 07/2006
2	Glutamic Acid (Glutamate)FDA Link 10/2007 - 11/2005
1	N-Methylaspartate (NMDA)IBA 12/2014
1	AMPA Receptors (AMPA Receptor)IBA 12/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2008
1	Therapeutic UsesIBA 01/2008
1	Aspartic Acid (Aspartate)FDA Link 10/2007
1	gamma-Aminobutyric Acid (GABA)IBA 08/2007
1	PlasticsIBA 08/2007
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2007
1	Calcineurin InhibitorsIBA 07/2006
1	CalcineurinIBA 07/2006
1	jasplakinolideIBA 01/2006
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2005
1	Dizocilpine Maleate (Dizocilpine)IBA 11/2005
1	EnzymesIBA 05/2005
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2005
1	protein kinase modulatorIBA 05/2005
1	N- (2- aminoethyl)- 5- isoquinolinesulfonamide (H-9)IBA 05/2005
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2005

Therapy/Procedure

1	Oral Administration 12/2014
1	Therapeutics 12/2014